Redefining the Future of Healthcare through Groundbreaking RNA Therapies
This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives:
- Industry Drivers and Challenges
- Technology Snapshot and Trends
- Clinical Pipeline Analysis
- Overview of the IP Landscape
- Innovator Profiles
- Future Roadmap
The RNA therapy platforms covered include:
- Splice-Switching Oligonucletides (SSO)
- Other Anti-Sense Oligonucleotide (ASO)
- Aptamers
- RNA-interference
- mRNA
- saRNA
An appendix is included, comprising lists of major industry influencers found in the study.
Table of Contents
1.0 EXECUTIVE SUMMARY
2.0 RNA THERAPIES: INDUSTRY OVERVIEW
3.0 TECHNOLOGY TRENDS & CLINICAL PIPELINE
4.0 OVERVIEW OF THE PATENT LANDSCAPE
5.0 INNOVATION PROFILES
6.0 FUTURE PERSPECTIVES
7.0 GROWTH OPPORTUNITIES AND COMPANIES TO ACTION
8.0 KEY INDUSTRY INFLUENCERS